Acurx Pharmaceuticals, Inc.
ACXP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,103 | -$14,578 | -$12,093 | -$12,748 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,436 | $3,766 | $3,302 | $6,742 |
| Change in WC | $284 | $1,011 | $1,248 | $141 |
| Other Non-Cash | $0 | $0 | $0 | $850 |
| Operating Cash Flow | -$10,383 | -$9,801 | -$7,542 | -$5,014 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $6,406 | $5,944 | $3,695 | $14,797 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $210 | $2,219 | $0 | $0 |
| Financing Cash Flow | $6,616 | $8,163 | $3,695 | $14,797 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,767 | -$1,638 | -$3,847 | $9,783 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,474 | $9,112 | $12,959 | $3,175 |
| End Cash | $3,707 | $7,474 | $9,112 | $12,959 |
| Free Cash Flow | -$10,383 | -$9,801 | -$7,542 | -$5,014 |